Reflecting on the adoption of AI in the workplace, it’s fascinating to see how AI, particularly ChatGPT, is becoming a staple in our personal and professional lives. Yet, there’s an undercurrent of concern—are we potentially engineering ourselves out of our own jobs?
We’re facing a significant dilemma: While employees leverage AI to enhance productivity, they’re also cautious about fully disclosing their methods to avoid job security concerns. This dichotomy mirrors the early days of social media, with initial enthusiasm giving way to the recognition of deeper societal impacts.
Recently, when speaking at the ReImagine Pharma Conference, I showcased examples where audiences had to guess if videos were AI-generated by Sora, OpenAI’s video-creation tool, or if they were created by a human team. The results often revealed the sophisticated capabilities of AI as well as its subtle imperfections. Would Sora’s impact rival how ChatGPT revolutionizes dialogue and MidJourney transforms creative processes?
Rapid advancements in AI, illustrated by ChatGPT's meteoric rise to 100 million users in two months, are unparalleled, leading to unprecedented changes in our professional landscape. However, such rapid integration brings trust issues to the forefront. The challenge is not just building new “glass skyscrapers” but ensuring our societal foundations are ready to support them.
It reminds me of Garry Kasparov’s experience in chess, where AI’s initial dominance led to his concept of “centaurs”—humans and AI collaborating to achieve unprecedented performance levels. For anyone with teens, I’m seeing a ton of them playing chess on their phones, getting ranked globally, and working to improve their positions. This has led to a surge in people playing chess globally and at higher levels than at any other time in history. Similarly, in the workplace, AI-enhanced humans are demonstrating measurable productivity, efficiency, and quality improvements.
Reflecting on data from a recent McKinsey report, we see AI driving significant gains in personalization, content generation, and feedback mechanisms, leading to improved response rates and reduced deployment costs. Our task is to apply these successes within the pharmaceutical and life sciences industries, optimizing both high-value strategic tasks and essential but repetitive low-value tasks.
At Klick, we’re embracing this challenge head-on. By leveraging AI for critical yet highly repeatable tasks as well as pioneering top-down innovations, such as diagnosing health conditions through voice biomarkers, we are enhancing productivity and addressing trust issues head-on.
The journey is complex, but AI’s potential to transform our industry is immense. I look forward to continuing this conversation and exploring how we can collectively navigate these transformative times.